GENEVA, Sept. 18 -- INNOCARE PHARMA INC. filed a patent application (US2026/017227) for “HETEROCYCLIC COMPOUNDS THAT INHIBIT TYROSINE KINASE 2 (TYK2) ACTIVITY”. With publication no. WO/2026/187632, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 25/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....